Home » IntelGenx Changes Manufacturing Site for CPI-300
IntelGenx Changes Manufacturing Site for CPI-300
IntelGenx Corp. announced a manufacturing site change for its antidepressant CPI-300, which it developed with Cary Pharmaceuticals.
CNNMoney
CNNMoney
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May